• Home
  • Study Details
By physician referral or invitation only

iSTAT Serum Biomarker Study

Glial fibrillary acidic protein (GFAP) and Ubiquitin carboxy-terminal hydrolase isozyme L1 (UCHL-1), are a protein and enzyme that are released in your body following injury to your neurons - specifically following a head injury. The measurement of these molecules has shown to have predictive value for potential complications related to head injuries (e.g. bleeding). This study seeks to determine if GFAP and UCHL-1 released by your body following a head injury can be used to predict the likelihood of such complications.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Brian Sindelar
Neurosurgery

Study Type

Clinical or Medical
Observational

Study Topics

Healthy Volunteer or General Population

IRB Number

22-1210

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research